Search research articles
Contact Us
Filters
Showing results (131-140 of 139) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 139 results.
Oncotarget
|
May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
Linda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Scientific Reports
|
June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
Ana Barat, Dominiek Smeets, Bruce Moran, et al.
Cell Reports. Medicine
|
August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Qiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
The Lancet. Digital Health
|
August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
Hannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
Journal of Hepatology
|
October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
JHEP Reports : Innovation in Hepatology
|
December 29, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
Bernhard Scheiner, Daniel Roessler, Samuel Phen, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 139) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 139 results.
Oncotarget
|
May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
Linda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Scientific Reports
|
June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
Ana Barat, Dominiek Smeets, Bruce Moran, et al.
Cell Reports. Medicine
|
August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Qiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
The Lancet. Digital Health
|
August 21, 2021
Development and validation of deep learning classifiers to detect Epstein-Barr virus and microsatellite instability status in gastric cancer: a retrospective multicentre cohort study
Hannah Sophie Muti, Lara Rosaline Heij, Gisela Keller, et al.
Journal of Hepatology
|
October 14, 2021
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score
Bernhard Scheiner, Katharina Pomej, Martha M Kirstein, et al.
JHEP Reports : Innovation in Hepatology
|
December 29, 2022
Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
Bernhard Scheiner, Daniel Roessler, Samuel Phen, et al.
Page
of 14